sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Brain Cancer Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00025904
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 151
Buy Now

North America Brain Cancer Diagnostics Market Analysis, Scope, and Growth by 2028

Buy Now

North America Brain Cancer Diagnostics Market Report North America Brain Cancer Diagnostics Market Size and Share North America Brain Cancer Diagnostics Market Scope and Analysis

North America Brain Cancer Diagnostics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 301.5 Million
Market Size by 2028 US$ 911.0 Million
Global CAGR (2021 - 2028) 17.1%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Diagnostic Type
  • Imaging Test
  • Lumbar Puncture
  • Biopsy
  • Molecular Testing
By Cancer Type
  • Acoustic Neuroma
  • Astrocytoma
  • Craniopharyngiomas
  • Ganglioneuromas
  • Glioblastoma Multiforme
  • Meningiomas
  • Ependymomas
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Siemens Healthineers A
  • GE Healthcare
  • MDxHealth
  • NantOmics
  • Biocept Inc
  • Koninklijke Philips N V
  • Canon Medical Systems
  • Hitachi Ltd